CAQK peptide

The CAQK peptide selectively targets injured brain tissue and demyelinating lesions by binding to an upregulated proteoglycan complex, without affecting healthy areas. Its ability to cross the blood-brain barrier makes it a promising tool for targeted drug delivery in neuroscience research, particularly in models of traumatic brain injury and multiple sclerosis.